Rebalix
Logo iSharesiShares · sheet of 10 September 2026
ETF sheet · official issuer and register data

iShares Listed Private Equity UCITS ETF

IPRA · IE000D8FCSD8 · USD · domicile Ireland
Equity · Global · Financials · Large capSFDR art. 6
Index tracked: S&P LISTED PRIVATE EQUITY INDEX (NET) (USD)
TER
0.75%+ trans. 0.10%
Fund size
85 m EUR
Tracking difference
−0.14%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 27 Jan 2022 · costs from the KID as of 2 Sept 2026 · 96 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the S&P Listed Private Equity Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed, and aims to invest in the equity securities (e.g. shares) that, so far as possible and practicable, make up the Index. The Index measures the performance of large, liquid, and listed private equity companies from developed markets. They…

Performance since series start (in euro) — base 100

27 Jan 202231 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202320242025202615580126
High 155 (31 Jan 2025) · low 80 (12 Oct 2022) · last 126. Past performance is not indicative of future results.

Returns in euro

1 year−8.7%
3 years+31.4%
5 yearsseries too young
10 yearsseries too young
Since series start+26.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)19.64%18.95%
Max drawdown−24.30%−25.17%
Sharpe-0.650.44
Sortino-0.860.60
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IPRA · IE000D8FCSD81
RebalixIPRA · IE000D8FCSD8 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+1.64%+1.80%−0.16%
2024+23.92%+24.04%−0.13%
2023+38.86%+38.97%−0.12%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 96 securities · top-10 weight = 52.0%
Top holdingsWeight
BLACKSTONE8.1%
BROOKFIELD CLASS A6.7%
3I GROUP PLC6.3%
KKR AND CO INC5.7%
APOLLO GLOBAL MANAGEMENT4.8%
WASHINGTON H SOUL PATTINSON & COMP4.3%
EQT4.2%
BROOKFIELD ASSET MANAGEMENT VOTING4.2%
ARES CAPITAL CORP3.9%
PARTNERS GROUP HOLDING AG3.9%
Countries (% of fund)
United States50.2%United Kingdom14.3%Canada13.0%Sweden6.0%Australia4.3%
Sectors (% of fund)
Financials99.5%Cash and/or Derivatives0.5%

Listing venues

ESMA register (FIRDS) and official exchange lists
CBUW · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/ipra-ishares-listed
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE000D8FCSD8
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IPRA · IE000D8FCSD82